Wertheimer Albert I, Norris Jeremiah
Temple University, School of Pharmacy, 3307 No. Broad Street, Philadelphia, PA 19140, USA.
Res Social Adm Pharm. 2009 Mar;5(1):4-16. doi: 10.1016/j.sapharm.2008.05.002.
Counterfeiting and the sale of substandard pharmaceutical products can no longer be ignored. At 10% of global trade, counterfeiting is affecting many countries, causing serious downstream expenses and resource shortages.
To describe the nature and impact of drug product counterfeiting and substandard product sale and to present strategies that may have value in ameliorating these phenomena.
A literature review was conducted, supplemented by interviews of key leaders/experts in the field and the search of relevant web sites. All of the data were combined, integrated, and coordinated to present the complete picture of this problem.
In addition to known corruption in some of the least developed countries, the trail through developed countries was detected. This report identifies means to detect faulty products and describes efforts toward resisting and ending these corrupt practices.
Counterfeit drugs, if not stopped, can be responsible for a macroeconomic pandemic where major portions of some populations may be too ill to work and where the health sector resources are completely overwhelmed, as with the case of HIV/AIDS.
假冒伪劣药品的制造与销售已不容忽视。假冒伪劣产品占全球贸易的10%，影响着许多国家，造成了严重的下游成本和资源短缺。
描述药品假冒伪劣和不合格产品销售的性质与影响，并提出可能有助于改善这些现象的策略。
进行文献综述，并辅以对该领域关键领导人/专家的访谈以及相关网站的搜索。所有数据进行了合并、整合与协调，以呈现该问题的全貌。
除了在一些最不发达国家存在的已知腐败现象外，还发现了假冒伪劣产品在发达国家的踪迹。本报告确定了检测不合格产品的方法，并描述了抵制和杜绝这些腐败行为的努力。
假药若不加以制止，可能引发一场宏观经济大流行，导致部分人群病得无法工作，卫生部门资源完全不堪重负，就像艾滋病的情况一样。
